Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125469892 | 12546989 | 2 | F | 20140929 | 20160803 | 20160711 | 20160809 | EXP | FR-AFSSAPS-MP20160706 | FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-44365FF | BOEHRINGER INGELHEIM | 72.62 | YR | F | Y | 0.00000 | 20160809 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125469892 | 12546989 | 1 | PS | MICARDIS | TELMISARTAN | 1 | Oral | 40 MG | 20850 | 40 | MG | TABLET | QD | ||||||
| 125469892 | 12546989 | 2 | SS | XANAX | ALPRAZOLAM | 1 | Oral | 1 MG | 0 | .5 | MG | TABLET | BID | ||||||
| 125469892 | 12546989 | 3 | SS | MIANSERINE | MIANSERIN HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
| 125469892 | 12546989 | 4 | SS | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Oral | 10 MG | 0 | 10 | MG | QD | |||||||
| 125469892 | 12546989 | 5 | C | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 1.2 MG | 0 | 1.2 | MG | QD | |||||||
| 125469892 | 12546989 | 6 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Oral | 25 MG | 0 | 25 | MG | TABLET | QD | ||||||
| 125469892 | 12546989 | 7 | C | PREVISCAN | FLUINDIONE | 1 | Oral | 0.75 MG | 0 | .75 | MG | QD | |||||||
| 125469892 | 12546989 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125469892 | 12546989 | 1 | Hypertension |
| 125469892 | 12546989 | 2 | Anxiety |
| 125469892 | 12546989 | 3 | Depression |
| 125469892 | 12546989 | 4 | Insomnia |
| 125469892 | 12546989 | 5 | Type 2 diabetes mellitus |
| 125469892 | 12546989 | 6 | Hypothyroidism |
| 125469892 | 12546989 | 7 | Product used for unknown indication |
| 125469892 | 12546989 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125469892 | 12546989 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125469892 | 12546989 | Confusional state | |
| 125469892 | 12546989 | Fall |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125469892 | 12546989 | 2 | 20140929 | 0 | ||
| 125469892 | 12546989 | 3 | 20140929 | 0 | ||
| 125469892 | 12546989 | 4 | 20140929 | 0 | ||
| 125469892 | 12546989 | 6 | 20140929 | 0 |